These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 9702769)

  • 1. Nutraceuticals: poised for a healthy slice of the healthcare market?
    Brower V
    Nat Biotechnol; 1998 Aug; 16(8):728-31. PubMed ID: 9702769
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutraceuticals: miracle or meme?
    Ridinger MH
    Clin Pharmacol Ther; 2007 Oct; 82(4):352-6. PubMed ID: 17851571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Public health. Toward evidence-based health claims for foods.
    Katan MB; de Roos NM
    Science; 2003 Jan; 299(5604):206-7. PubMed ID: 12522235
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech jostles with pharma for slice of HIV market.
    Katsnelson A
    Nat Biotechnol; 2006 Jan; 24(1):3-4. PubMed ID: 16404375
    [No Abstract]   [Full Text] [Related]  

  • 5. From aspartame to Xenical. A look at the FDA review process.
    Trissler RJ
    J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
    [No Abstract]   [Full Text] [Related]  

  • 6. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(57):14451. PubMed ID: 10558410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Billion-dollar market blossoms as botanicals take root.
    Glaser V
    Nat Biotechnol; 1999 Jan; 17(1):17-8. PubMed ID: 9920256
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 9. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotechnology: will it break the health care bank?
    McGivney WT
    Physician Exec; 1992; 18(5):35-6. PubMed ID: 10121675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Market watch: upcoming market catalysts in Q4 2010.
    Rosenthal J
    Nat Rev Drug Discov; 2010 Oct; 9(10):755. PubMed ID: 20885399
    [No Abstract]   [Full Text] [Related]  

  • 12. Alternative medicine--the case of herbal remedies.
    Dickinson A
    N Engl J Med; 1999 Feb; 340(7):564; author reply 566. PubMed ID: 10026039
    [No Abstract]   [Full Text] [Related]  

  • 13. Nutraceuticals and functional foods regulations in the United States and around the world.
    Bagchi D
    Toxicology; 2006 Apr; 221(1):1-3. PubMed ID: 16487648
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical manufacturers ... leaving tradition behind and forging new managed care alliances.
    Barnett AA
    State Health Care Am; 1995; ():41-6. PubMed ID: 10168072
    [No Abstract]   [Full Text] [Related]  

  • 15. How pharmacogenomics will impact the federal regulation of clinical trials and the new drug approval process.
    Binzak BA
    Food Drug Law J; 2003; 58(1):103-27. PubMed ID: 12739592
    [No Abstract]   [Full Text] [Related]  

  • 16. US Food and Drug Administration regulations governing label claims for food products, including probiotics.
    Saldanha LG
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S119-21; discussion S144-51. PubMed ID: 18181715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative medicine--the risks of untested and unregulated remedies.
    Angell M; Kassirer JP
    N Engl J Med; 1998 Sep; 339(12):839-41. PubMed ID: 9738094
    [No Abstract]   [Full Text] [Related]  

  • 18. The changing environment for technological innovation in health care.
    Goodman CS; Gelijns AC
    Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investing in risk management.
    Fiscus PW
    Nat Biotechnol; 1997 Jan; 15(1):88-9. PubMed ID: 9035113
    [No Abstract]   [Full Text] [Related]  

  • 20. So you want to market a food and to make health-related claims--how far can you go? What rules of law will govern the claims you want to make?
    McNamara SH
    Food Drug Law J; 1998; 53(3):421-36. PubMed ID: 10346720
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.